Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy.

Journal of cellular and molecular medicine - 1 Jun 2010

Gaipa Giuseppe, Tilenni Manuela, Straino Stefania, Burba Ilaria, Zaccagnini Germana, Belotti Daniela, Biagi Ettore, Valentini Marco, Perseghin Paolo, Parma Matteo, Campli Cristiana Di, Biondi Andrea, Capogrossi Maurizio C, Pompilio Giulio, Pesce Maurizio

Abstract excerpt

The aim of the present study was to develop and validate a good manufacturing practice (GMP) compliant procedure for the preparation of bone marrow (BM) derived CD133(+) cells for cardiovascular repair. Starting from available laboratory protocols to purify CD133(+) cells from human cord blood, w...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AC133 Antigen
Share to Fetal Blood

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hindlimb

Share to Myocardial Ischemia

Share to Quality Control

Share to Reference Standards

Share to Stem Cell Transplantation

Share to Vascular Endothelial Growth Factor Receptor-2

Source

Open in PubMed Open full text

Identifiers

PMID: 19627397
DOI: 10.1111/j.1582-4934.2009.00854.x
PMCID: PMC3829025

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19627397-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy.PMID 19627397Read ↗

Development of a potency assay for CD34+ cell-based therapy for post-acute myocardial infarctionSemantic proximity Read ↗

Quality assessment of a serum and xenofree medium for the expansion of human GMP-grade mesenchymal stromal cells.Semantic proximity Read ↗

Good Manufacturing Practice–compliant human induced pluripotent stem cells: from bench to putative clinical productsSemantic proximity Read ↗

In vitro expansion of human cardiac progenitor cells: exploring 'omics tools for characterization of cell-based allogeneic products.Semantic proximity Read ↗

Mesenchymal Stromal Cells Can Be Derived From Bone Marrow CD133 <sup>+</sup> Cells: Implications for TherapySemantic proximity Read ↗

In vitro functional comparison of therapeutically relevant human vasculogenic progenitor cells used for cardiac cell therapy.Semantic proximity Read ↗

GMP-compatible manufacturing of three iPS cell lines from human peripheral bloodSemantic proximity Read ↗

Scalable Generation of Universal hiPSC-Derived Vascular Progenitor Cells for Safe and Sustained Revascularization in Chronic Limb-Threatening IschemiaSemantic proximity Read ↗

Are purified or expanded cord blood-derived CD133+ cells better at improving cardiac function?Semantic proximity Read ↗

Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experienceSemantic proximity Read ↗

A comparative experimental study of the efficacy and safety of Quality and Quantity media-cultured mononuclear cell transplantation in ischemic hindlimb mouse modelSemantic proximity Read ↗

Quality and Quantity culture media effectively restored the number and vasculogenic function of mononuclear cells from chronic limb- threatening ischemia patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.